Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Share-based Compensation (2017 - 2026)

Rocket One's (RKTO) quarterly Share-based Compensation came in at $2.3 million in Q2 2026, up 83.31% year-over-year from $1.3 million in Q2 2025, and up 83.31% quarter-over-quarter from $1.3 million in Q1 2026.

Analysis

Rocket One (RKTO) Share-based Compensation (2017 - 2026) Analysis & Trends

Rocket One has disclosed Share-based Compensation across 10 years of filings, most recently posting $2.3 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 83.31% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $2.3 million (up 83.31% YoY), while the FY2025 annual figure was $1.5 million, up 39.5% from the prior year.
  • Share-based Compensation came in at $2.3 million for Q2 2026 at Rocket One, up from $1.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q2 2026 to a low of $541.0 in Q4 2024.
  • Average Share-based Compensation over 5 years is $605940.8, with a median of $383851.5 recorded in 2022.
  • Year-over-year, Share-based Compensation plunged 98.82% in 2022 and soared 20426.8% in 2025.
  • Over 5 years, Share-based Compensation stood at $15468.0 in 2022, then tumbled by 62.6% to $5785.0 in 2023, then plunged by 90.65% to $541.0 in 2024, then soared by 20426.8% to $111050.0 in 2025, then jumped by 1980.47% to $2.3 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $2.3 million in Q2 2026, $1.3 million in Q1 2026, and $111050.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 83.34 Mn
10 Rocket One 13.86 Mn 5.97 Mn - 2.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.31 Mn
Mar 31, 2026 1.26 Mn
Dec 31, 2025 111,050.00
Sep 30, 2025 1.26 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 541.00
Sep 30, 2024 1.09 Mn
Jun 30, 2024 617,362.00
Mar 31, 2024 617,362.00
Dec 31, 2023 5,785.00
Sep 30, 2023 190,265.00
Jun 30, 2023 104,651.00
Mar 31, 2023 104,651.00
Dec 31, 2022 15,468.00
Sep 30, 2022 104,651.00
Jun 30, 2022 15,538.00
Mar 31, 2022 577,438.00
Dec 31, 2021 125,991.00
Sep 30, 2021 1.32 Mn